Point72 Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Point72 Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-569,146	Closed	-$88.7M	–	2163
2025 Q1	$88.7M	Buy	569,146 +65,477	+13%	+$9.35M	0.2%	112
2024 Q4	$69.3M	Buy	503,669 +8,122	+2%	+$1.07M	0.15%	150
2024 Q3	$74M	Buy	+495,547	New	+$66.9M	0.19%	130
2023 Q2	–	Sell	-771,110	Closed	-$67.1M	–	2162
2023 Q1	$82.7M	Buy	771,110 +396,400	+106%	+$45.3M	0.26%	92
2022 Q4	$45.8M	Sell	374,710 -9,490	-2%	-$1.1M	0.16%	172
2022 Q3	$39.7M	Buy	+384,200	New	+$36.4M	0.16%	167
2022 Q1	–	Sell	-112,200	Closed	-$15.1M	–	1160
2021 Q4	$15.1M	Buy	112,200 +19,891	+22%	+$2.96M	0.06%	400
2021 Q3	$14.7M	Buy	92,309 +7,209	+8%	+$987K	0.06%	394
2021 Q2	$11.2M	Buy	85,100 +50,100	+143%	+$6.68M	0.05%	422
2021 Q1	$4.51M	Sell	35,000 -6,700	-16%	-$1.02M	0.02%	593
2020 Q4	$6.96M	Buy	+41,700	New	+$6.9M	0.03%	526
2020 Q2	–	Sell	-72,600	Closed	-$8.18M	–	797
2020 Q1	$8.18M	Buy	+72,600	New	+$9.43M	0.07%	326

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Point72 Asset Management's ASND Position: Q2 2025 in Review

Point72 Asset Management sold out of Ascendis Pharma A/S (ASND) in Q2 2025, closing a stake of 569,146 shares — an estimated $88.7M sold.

Point72 Asset Management first reported a position in ASND in Q1 2020 and held it in 12 quarters. The position peaked at $88.7M in Q1 2025. 247 funds tracked by Wall St. Rank hold ASND as of Q2 2025.

Point72 Asset Management reported no remaining Ascendis Pharma A/S position as of Q2 2025 after selling out during the quarter.
Point72 Asset Management sold 569,146 Ascendis Pharma A/S shares in Q2 2025, an estimated $88.7M.
Point72 Asset Management first reported a position in Ascendis Pharma A/S in Q1 2020 and held it in 12 quarters.
Point72 Asset Management's Ascendis Pharma A/S position peaked at $88.7M in Q1 2025.
247 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2025.

Based on Point72 Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.